---
schema_version: "secwatch.filing_event.v1"
accession: "0001708599-25-000065"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2025-07-01T23:59:59+00:00"
generated_at: "2026-05-18T10:12:22.570762+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Serina Therapeutics sets 2025 annual meeting for Nov 7; updates proposal deadlines

## Summary
- Annual meeting scheduled for November 7, 2025; location and time in proxy.
- Rule 14a-8 stockholder proposals must be received by August 15, 2025.
- Director nominations and other proposals due August 9, 2025; earliest July 10.
- Meeting date change of >30 days from 2024 anniversary triggers adjusted deadlines.

## SEC filing metadata
- accession: 0001708599-25-000065
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2025-07-01T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.08, 8.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000170859925000065/0001708599-25-000065-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000170859925000065/ser-20250701.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001708599-25-000065
- JSON: https://secwatch.observer/filing/0001708599-25-000065.json
- Plain text: https://secwatch.observer/filing/0001708599-25-000065.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.